Chronic and hard-to-heal wounds remain a significant clinical challenge across acute, post-acute, and outpatient settings. When wounds stall, patients face prolonged healing timelines, increased infection risk, and diminished quality of life. UltraMIST Therapy, provides a clinically proven, non-contact modality designed to help restart the body’s normal healing process in stalled wounds.
WHAT IS SANUWAVE ULTRAMIST?
UltraMIST Therapy is a clinically proven treatment that delivers low-energy, low-frequency ultrasound to the wound bed via a saline or fluid mist. This method allows ultrasound energy to be delivered without direct contact, making the therapy non-contact and non-thermal.
Unlike many wound care modalities that treat only the wound surface, UltraMIST ultrasound waves penetrate into and below the wound to support the body’s normal healing process.
HOW DOES SANUWAVE ULTRAMIST ACCELERATE HEALING?
When wounds stall, cellular activity slows and healing progression is delayed. UltraMIST Therapy delivers ultrasound energy that helps “jump-start” cellular activity within the wound to reinitiate healing. Acoustic waves mechanically stimulate the cells in and below the wound surface to promote healing. The pressure from the acoustic waves is enough to:
- Clack the fragile cell walls of bacteria, decreasing bacteria & biofilm
- Remove pro-inflammatory cytokines, reducing Inflammation
- Tug on healthy cells to increase blood flow
WHO CAN USE SANUWAVE ULTRAMIST THERAPY?
UltraMIST Therapy has been clinically proven to promote healing across a wide range of chronic and acute wounds, including but not limited to:
- Venous leg ulcers
- Pressure ulcers
- Diabetic foot ulcers
- Deep tissue pressure injuries
- Surgical wounds
This broad applicability makes UltraMIST Therapy suitable for use across multiple care settings and patient populations.
SANUWAVE ULTRAMIST TREATMENT DELIVERY
UltraMIST Therapy is designed for efficient integration into existing wound care protocols. Typical treatment times range from 3 to 20 minutes, depending on wound size. Therapy can be delivered as a standalone modality or in conjunction with existing wound care treatments in hospital or outpatient clinic settings.
During treatment, clinicians position the applicator approximately 0.5–1.5 cm from the wound in a perpendicular orientation. The treatment wand is moved slowly in horizontal and vertical passes across the wound bed to ensure even ultrasound delivery. The system provides audible confirmation when treatment is complete.
To support smooth adoption, OX BioMed provides structured onboarding, clinical training, and ongoing support to help care teams implement UltraMIST confidently and consistently within their existing workflows.
BRING ULTRAMIST INTO YOUR PRACTICE WITH CONFIDENCE
As healthcare organizations look to advance wound care outcomes without adding operational complexity, choosing the right partner is just as important as choosing the right therapy. OX BioMed supports clinicians by providing access to UltraMIST Therapy alongside the expertise, infrastructure, and ongoing support needed for successful implementation.
By partnering with OX BioMed, care teams gain a trusted resource dedicated to helping them integrate clinically proven technologies, optimize workflows, and ultimately deliver better healing outcomes for patients across every stage of care.
For more information or to speak with a clinican expert visit www.oxbiomed.com.ox-ultramist/.
Source: SANUWAVE Health, Inc. website: www.sanuwave.com and approved UltraMIST® marketing materials; OX BioMed authorized retailer content.